Dark

PDLI
PDL BioPharma, Inc. Common Stock
stock NASDAQ

Inactive

Dec 30, 2020 3:59:00 PM EST

2.48USD-8.487%(-0.23)2,353,432

Pre-market

Dec 31, 1969 7:00:00 PM EST

0.00USD-100.000%(-2.68)0

After-hours

Dec 31, 1969 7:00:00 PM EST

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

CEO

John McLaughlin

Headquarters

Incline village, Nevada, USA

Industry

Biotechnology

Last Split

Oct 10, 20012for1

AMGN SGMO CGEN NKTR BTX LLY MYL XLV

Profile

PDL BioPharma Inc is engaged in the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It focuses on intellectual property asset management, investing in new royalty bearing assets and maximizing value of its patent.